Category: Cannabis Studies

Peer-reviewed studies covering cannabis and cannabis compounds.

Nanoencapsulated CBD May Reduce Panic-Like Responses, Finds Study

A study published today by the International Journal of Pharmaceutics finds that nanoencapsulated cannabidiol (CBD) may significantly reduce panic-like behaviors. Researchers from the University of São Paulo, the Federal University of Rio Grande do Sul, and the University of Poonch Rawalakot explored how nanoencapsulation—specifically, polymeric lipid core-based technology—affects CBD’s impact on defensive behaviors triggered by exposure …

Continue reading

Study: Low-Dose CBD Reverses Depression-Like Effects of Chronic Stress in Animal Model

A new study published in Neuropharmacology has found that an ultra-low dose of cannabidiol (CBD) may effectively reverse some of the behavioral and molecular effects of chronic stress, a major factor contributing to depression. Researchers from the University of Barcelona and the University of Greifswald administered a low dose of CBD (1 mg/kg) to mice …

Continue reading

Study: End-of-Day Far-Red Light Boosts THC Levels in Cannabis, Reduces Energy Use

A study published in the journal Scientific Reports has found that adding far-red light at the end of the day can significantly boost THC levels in some cannabis strains while reducing overall energy consumption. For the study, researchers from Australia compared six lighting treatments across three popular genotypes—Cannatonic, Hindu Kush, and Northern Lights—exploring whether a …

Continue reading

New Non-Hallucinogenic LSD Compound May Offer Mental Health Benefits Without the Trip

A team of chemists at the University of California, Davis has developed a modified version of LSD that may offer the drug’s therapeutic benefits without its mind-altering effects. The newly created compound, known as JRT, maintains LSD’s ability to stimulate brain cell growth, a promising effect for treating conditions like depression and schizophrenia. But unlike …

Continue reading

Study: Ketamine, Psilocybin, and Esketamine Offer Rapid Relief and Functional Benefits in Treatment-Resistant Depression

A new systematic review published in the journal Cureus finds that psychedelic-assisted therapies such as ketamine, esketamine, and psilocybin may offer fast-acting and sustained relief for those with treatment-resistant depression (TRD), while also improving real-world functioning. The review analyzed 10 randomized controlled trials published within the past year, all of which assessed various psychedelic agents …

Continue reading

Cannabinoids Discovered in Rhododendron Plant

Researchers have identified two cannabinoids and three other bioactive compounds in Rhododendron, a plant native to Pakistan that has long been used in traditional medicine. In a study published in Natural Product Research, scientists from the University of Swat and the Royal Botanic Gardens Kew in the UK analyzed the leaves of Rhododendron anthopogon, a …

Continue reading

Study: Full-Spectrum Cannabis Extract May Aid Gut and Organ Recovery After Stroke

According to the results of a new study published in Inflammopharmacology, full-spectrum cannabis sativa extract (FSC) may offer significant benefits in protecting the gut and peripheral organs following an ischemic stroke. Researchers from Brazil, Canada, and the United States examined the effects of FSC on male Wistar rats that underwent a 60-minute middle cerebral artery …

Continue reading

Study: CBD Oil May Reduce Autism Symptoms and Oxidative Stress

A study published today by the journal Developmental Neurobiology found that cannabidiol (CBD) oil may improve core symptoms of autism and reduce oxidative stress. Researchers from several Pakistani institutions, including the National University of Sciences and Technology and Quaid-i-Azam University, examined the effects of CBD oil on mice with autism-like behaviors induced by valproic acid …

Continue reading

Study: 10% Price Drop Boosts Legal Cannabis Sales 14% in British Columbia

A new study has found that demand for legal cannabis in British Columbia is significantly influenced by price, with consumers responding strongly to price decreases in the post-legalization market. Researchers from the BC Ministry of Public Safety and Solicitor General and the Ministry of Agriculture and Food analyzed wholesale cannabis sales data from June 2022 …

Continue reading

Study: Alcohol Sales Declined in Nova Scotia Following Marijuana Legalization

A new study finds that alcohol sales in Nova Scotia declined modestly following the legalization of recreational marijuana. The research, published in the International Journal of Drug Policy and conducted by Brock University, examined monthly alcohol sales across government-owned stores over a 34-month span—17 months before and 17 months after legalization, which began in October …

Continue reading